An interventional study of Trendelenburg maneuver and End-expiratory occlusion test (EE OCC) in Acute Respiratory Distress Syndrome, sponsored by Hospices Civils de Lyon. Recruiting at 4 sites in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-01-18.
Sponsored by Hospices Civils de Lyon · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 15 studies in Respiratory Distress Syndrome by Hospices Civils de Lyon — 2 open to participants now, 2 under way, none of them phase 3. Respiratory Distress Syndrome · Hospices Civils de Lyon.
Among the 15 studies in Respiratory Distress Syndrome by Hospices Civils de Lyon, this one is the 3rd largest by planned enrollment of the 13 interventional ones that give a count, is the only one that started in 2023, is one of 13 with no phase, and was the 14th registered.
1,389 studies on the registry are indexed under Respiratory Distress Syndrome; 281 are open to participants now.
Browse Respiratory Distress Syndrome studies →2 of the 15 studies in Respiratory Distress Syndrome by Hospices Civils de Lyon are open now, in 1 country. Recruiting first, the newest first:
Hospices Civils de Lyon · Sites in France
Ages 15+
By country, each count listing its studies:
Of the 196 Respiratory Distress Syndrome studies recruiting now, 116 (59%) set no upper age limit and 50 (26%) stop at 75 or younger; 52 take children under 18; 9 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
15 studies; the count open now beside each. This study's row is marked.
First in 2008; this study’s year is marked. 1 started in 2023.
This study's planned enrollment of 96 is above the median of 60 across 823 interventional studies indexed under Respiratory Distress Syndrome.
Median enrollment 31 across the 13 interventional studies, 473 across the 2 observational. Of the 13 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Hospices Civils de Lyon is the lead sponsor of 1,868 studies on the registry; 447 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 15 studies in Respiratory Distress Syndrome by Hospices Civils de Lyon, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Predicting fluid responsiveness is primordial when caring for patients with circulatory shock as it allows correction of preload-dependent low cardiac output states, while preserving patients of the deleterious effects of excessive fluid resuscitation.
Patients with severe acute respiratory distress syndrome (ARDS) treated with prone positioning (PP) are a specific subset of patients, as 1) they frequently present with shock; 2) excessive fluid administration may lead to respiratory worsening due to increased hydrostatic oedema with potential subsequent worse clinical outcome; and 3) all available dynamic tests evaluating fluid responsiveness can only be performed in patients in the supine condition (which in the case of severe ARDS patients in PP occurs only for 8h over 24h). These elements warrant the development of specific tests allowing the clinician to predict fluid responsiveness with enough exactitude when caring for these patients.
We hypothesize that there exists diagnostic heterogeneity in the predictive performance of 4 clinical tests to identify fluid responsiveness in ARDS patients in PP. For the matter of this study, these 4 tests are the Trendelenburg maneuver, the end-expiratory occlusion test, the end-expiratory occlusion test associated with the end-inspiratory occlusion test, and the tidal volume challenge. The diagnostic reference of the study will be the relative change in cardiac index measured by transpulmonary thermodilution before and after a 500 ml fluid bolus, and will allow the adjudication of patients as being fluid responsive or not.
The primary objective of the study is to determine the area under the ROC curve of each of the 4 tests, with their respective 95% confidence interval.
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. Patients will only participate once. The expected duration of study participation is 30 minutes maximum.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.
Child-Pugh class
A score of how well the liver works in people with liver disease such as cirrhosis: class A is mild, B moderate and C severe.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
All enrolled patients will perform the 4 tests following a cross-over design and in a randomized sequence, separated by 1-min wash-out periods with return to hemodynamic baseline values, and concluded with the 500-ml fluid bolus. There are 24 different possibilities of sequence
Diagnostic Test: Trendelenburg maneuver · Diagnostic Test: End-expiratory occlusion test (EE OCC) · Diagnostic Test: End-expiratory and end-inspiratory occlusion test (EI OCC) · Diagnostic Test: Tidal volume challenge · Diagnostic Test: Fluid bolus (reference diagnostic method)
Bed tilting from the +13° position to the -13° position for 60 seconds. Evaluator: relative change in continuous cardiac index between baseline, and the highest value observed during the maneuver
End-expiratory pause performed on the ventilator, and maintained for 15 seconds. Evaluator: relative change in continuous cardiac index between baseline, and the value observed in the last 5 seconds of the respiratory pause
End-inspiratory pause performed on the ventilator, and maintained for 15 seconds. Evaluator: relative change in continuous cardiac index between baseline, and the value observed in the last 5 seconds of the respiratory pause. The evaluator is calculated as the sum of the relative change in cardiac index observed during the end-expiratory pause and that of the end-inspiratory pause. Hence, for this test, the evaluator will be coupled with that of intervention 2 (end-expiratory occlusion test).
Increase in tidal volume set on the ventilator from 6 ml.kg-1 of predicted body weight, to 8 ml.kg-1 for 60 seconds. Evaluator: difference in the pulse pressure variation measured at 6 ml.kg-1 and at 8 ml.kg-1.
After the 4 tests, the patient will receive a 500-ml fluid bolus of crystalloids in less than 15 minutes. Evaluator (reference method): cardiac index measured by transpulmonary thermodilution before and immediately after the fluid bolus. Patients with a relative change in cardiac index \> 15% will be identified as being fluid responders, and the others as non-responders.
Area under the ROC curve (AUROC) of the evaluated tests.
The AUROC will be determined for each of the 4 clinical tests evaluated in this study. The reference method to define the AUROC to design the curve will be the fluid responsive status (responder vs. non-responder) as determined by the fluid bolus. For each test, the AUROC will be accompanied with its 95% confidence interval.
Time frame: 30 minutes
Comparison of diagnostic performance of the evaluated tests.
For this outcome measure, the AUROCs will be determined as for the primary outcome measure. The AUROCs will be compared using the Delong's method, with adjustments for the repetition of measurements in a single patient.
Time frame: 30 minutes
Diagnostic performance metrics of each test
Sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratios of the evaluated tests, computed for the optimal diagnostic threshold determined using the Youden J index of the ROC curve. The optimal threshold will only be computed for AUROCs significantly different from 0.5.
Time frame: 30 minutes
Weighted diagnostic performance of each test
Sensitivity, specificity, positive predictive value, negative predictive value and likelihood ratios of the evaluated tests, computed for the optimal diagnostic threshold determined using the Youden J index of the ROC curve, and adjusted using weighting based on the clinical tradeoff of the subsequent fluid bolus on hemodynamic benefit vs. the respiratory risk. The optimal threshold will only be computed for AUROCs significantly different from 0.5.
Time frame: 30 minutes
Grey zone area of the optimal diagnostic threshold of each test
Determination of the boundaries of a grey zone around the value of the optimal threshold of each test, in which the diagnostic performance is deemed clinically insufficient (excessive misclassification risk due to lack of discrimination). The grey zone around the optimal threshold will only be computed for AUROCs significantly different from 0.5.
Time frame: 30 minutes
Started Oct 2023 (actual). Primary completion is estimated for Oct 2026, 36 months after the start.
Of 266 non-industry interventional studies with no phase under Respiratory Distress Syndrome, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 42. This study's planned 36 months is above that.
Counting every sponsor, half of 273 studies reached it within 24 months; a quarter within 12 and three quarters within 42.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Respiratory Distress Syndrome →